pyrazines has been researched along with nusinersen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hussar, DA | 1 |
| Carey, KA; Farrar, MA; Jones, KJ; Kariyawasam, D | 1 |
1 review(s) available for pyrazines and nusinersen
| Article | Year |
|---|---|
New and developing therapies in spinal muscular atrophy.
Topics: Cholestenones; Genetic Therapy; Humans; Imidazoles; Neuroprotective Agents; Oligonucleotides; Physical Therapy Modalities; Pyrazines; Respiration, Artificial; Spinal Muscular Atrophies of Childhood; Survival of Motor Neuron 1 Protein; Survival of Motor Neuron 2 Protein | 2018 |
1 other study(ies) available for pyrazines and nusinersen
| Article | Year |
|---|---|
New Drugs 2017, part 3.
Topics: Acetamides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antitoxins; Bridged Bicyclo Compounds, Heterocyclic; Carbazoles; Chenodeoxycholic Acid; Drug Approval; Humans; Indoles; Morpholinos; Oligonucleotides; Piperidines; Polydeoxyribonucleotides; Pyrazines; Sulfonamides; United States; United States Food and Drug Administration | 2017 |